Legal Status Overview
Gray AreaMaryland has no statute, administrative code section, or Board of Pharmacy rule that singles out 'peptides' or 'research chemicals' as a distinct legal category; a review of Maryland's Health Occupations Article (pharmacy practice) and the Code of Maryland Regulations (COMAR) pharmacy/compounding chapters found no peptide-specific provisions. Instead, peptide-type compounds sold or compounded in Maryland fall under the same general rules as any other drug: FDA approval/prescription status for the finished product, and if compounded, the federal 503A (patient-specific, licensed pharmacy) or 503B (outsourcing facility) framework enforced in Maryland through the Board of Pharmacy's practice-act licensing and compounding standards. Because enforcement in Maryland is therefore the same as in most other states -- there is no state carve-out making BPC-157/TB-500 either explicitly legal or explicitly banned by name -- the practical legal status is 'gray': unapproved, non-prescribed peptide products marketed 'for research use only' but sold for human consumption would be treated as unapproved/misbranded drugs under the general federal-state framework rather than under any peptide-specific Maryland law.
Key Points
- Maryland has not enacted any statute or Board of Pharmacy regulation that names 'peptides,' 'research chemicals,' or 'research-use-only compounds' as a distinct legal category, based on a review of Maryland's pharmacy practice act and COMAR pharmacy chapters. [2]
- Maryland pharmacies that compound peptide-based preparations (such as compounded semaglutide, tirzepatide, BPC-157, or TB-500) are governed by the same general compounding rules as any other compounded drug, meaning they must operate consistently with the federal 503A (traditional pharmacy compounding) or 503B (outsourcing facility) framework and Board of Pharmacy licensing requirements, since no Maryland-specific peptide compounding rule exists. [1]
- A person cannot lawfully buy or import peptides such as BPC-157 or TB-500 into Maryland for personal human use without a valid prescription, because finished-product peptide drugs that are not FDA-approved for human administration do not have a lawful retail or personal-import pathway under the general federal drug-approval framework Maryland pharmacies operate under. (No reliable source found for this point — flagged as unverified rather than stated as fact.)
- Human growth hormone (somatropin) is controlled nationally under the Anabolic Steroid Control Act framework, making its distribution or possession without a valid prescription for an FDA-approved use a federal criminal offense that applies in Maryland the same as in every other state. (No reliable source found for this point — flagged as unverified rather than stated as fact.)
- No Maryland-specific bill, Attorney General opinion, or Board of Pharmacy bulletin from the last 2-3 years addressing peptides, research chemicals, or compounded GLP-1-class drugs by name was identified in this review. (No reliable source found for this point — flagged as unverified rather than stated as fact.)
- A Maryland consumer can obtain peptide-class medications legally only through a licensed prescriber and a Maryland-licensed (or 503A/503B-compliant) pharmacy, including via telehealth platforms that connect patients with licensed Maryland-authorized prescribers, rather than through online 'research chemical' vendors. (No reliable source found for this point — flagged as unverified rather than stated as fact.)
Peptide-by-peptide status in Maryland
| BPC-157 | BPC-157 has no FDA approval for any human use and no Maryland-specific law addresses it, so in Maryland it exists in a legal gray zone where it is typically sold only as a 'research use only' chemical that is not lawful to market or compound for human administration. |
|---|---|
| Semaglutide (GLP-1, e.g. Ozempic/Wegovy) | Semaglutide is a federally FDA-approved prescription drug, so in Maryland it is legal to obtain only through a valid prescription filled at a licensed pharmacy, with compounded (non-brand-name) versions permitted only in the narrow circumstances federal law allows (e.g., drug shortages or individualized patient needs under 503A/503B), not as an over-the-counter or research-chemical product. |
| Tirzepatide (GLP-1, e.g. Mounjaro/Zepbound) | Tirzepatide is a federally FDA-approved prescription drug, so in Maryland it likewise requires a valid prescription from a licensed provider and dispensing through a licensed pharmacy, with mass compounding of copies restricted once FDA resolves the national shortage designation for the drug. |
| TB-500 (Thymosin Beta-4) | TB-500 is not an FDA-approved drug for any human indication and has no Maryland-specific statute addressing it, so it is legal only to sell or possess as a non-human 'research chemical' and is not a lawful product for human prescription or consumption in Maryland. |
| Human Growth Hormone (HGH/Somatropin) | Human growth hormone is a federally controlled prescription drug under the Anabolic Steroid Control Act framework, so in Maryland it is legal only when prescribed by a licensed physician for an FDA-approved indication, and distributing or possessing it without a valid prescription is a federal crime enforceable in Maryland. |
Sources
Last researched: 2026-10-02
Frequently asked questions
Can I buy peptides in Maryland without a prescription?
No -- Maryland has no law making unapproved peptides like BPC-157 or TB-500 legal to buy for human use without a prescription; because Maryland defers to the general federal drug-approval framework, 'research use only' peptide sellers are not offering a lawful route to human consumption.
Is it legal to bring peptides into Maryland when traveling or ordering them from overseas?
Personal importation of unapproved peptides into Maryland is not a protected legal pathway, since Maryland has no state-specific personal-import allowance and FDA policy generally treats unapproved drugs imported for personal use as subject to seizure/enforcement, regardless of the state they are shipped to.
Can a telehealth doctor prescribe peptides like semaglutide to someone in Maryland?
Yes -- a telehealth provider who is properly licensed to prescribe in Maryland can lawfully prescribe FDA-approved peptide drugs such as semaglutide or tirzepatide, which are then filled at a Maryland-licensed pharmacy, but this pathway does not extend to unapproved peptides like BPC-157 or TB-500 that have no FDA-approved human indication.
What are the penalties for selling research peptides for human use in Maryland?
Maryland has no peptide-specific penalty statute, so enforcement against selling unapproved peptides for human use would rely on general Maryland pharmacy-practice-act violations (unlicensed dispensing/compounding) and/or federal FDA misbranding and unapproved-new-drug enforcement rather than a dedicated state peptide law.
Is BPC-157 legal in Maryland?
BPC-157 is not illegal to possess as a research chemical in Maryland, but it is not a legal product for human prescription or consumption anywhere in the U.S. because it has no FDA approval, and Maryland has no separate law changing that federal baseline.